Evidence map›Paper›PMID 33687214›Full record

ArticleACS nano2021

Sequencing-Based Protein Analysis of Single Extracellular Vesicles.

Jina Ko, Yongcheng Wang, Kuanwei Sheng, David A Weitz, Ralph Weissleder

Open access · greenAbstract read
In one paragraph

Article in ACS nano, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 123 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Biogenesis and functional implications of extracellular vesicles in cancer metastasis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jina KoCenter for Systems Biology, Massachusetts General Hospital, 185 Cambridge Street, CPZN 5206, Boston, Massachusetts 02114, United States.
Yongcheng WangWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts 02115, United States.
Kuanwei ShengWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts 02115, United States.
David A WeitzWyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts 02115, United States.ORCID 0000-0001-6678-5208
Ralph WeisslederCenter for Systems Biology, Massachusetts General Hospital, 185 Cambridge Street, CPZN 5206, Boston, Massachusetts 02114, United States.ORCID 0000-0003-0828-4143
Harvard University · US

Funding

The role of microvesicles in giloma virotherapyP01CA069246 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI CARTER, BOB S · 1996 to 2021
$30.9M
Multiplexed analysis of exosomes in cancer nano therapyR01CA204019 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2016 to 2020
$1.9M
Mapping Single Extracellular Vesicles to Parent Cells for Immunotherapy MonitoringR00CA256353 · NCI · UNIVERSITY OF PENNSYLVANIA · PI KO, JINA · 2022 to 2024
$741k
Single Circulating Vesicle Analysis for Early Cancer DetectionR21CA236561 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2019 to 2021
$585k
Mapping Single Extracellular Vesicles to Parent Cells for Immunotherapy MonitoringK99CA256353 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI KO, JINA · 2021 to 2021
$178k
NCI NIH HHS K99 CA256353NCI NIH HHS P01 CA069246NCI NIH HHS R00 CA256353NCI NIH HHS R01 CA204019NCI NIH HHS R21 CA236561
6 · The paper itself

Abstract

Circulating extracellular vesicles (EVs)-biological nanomaterials shed from most mammalian cells-have emerged as promising biomarkers, drug delivery vesicles, and treatment modulators. While different types of vesicles are being explored for these applications, it is becoming clear that human EVs are quite heterogeneous even in homogeneous or monoclonal cell populations. Since it is the surface EV protein composition that will largely dictate their biological behavior, high-throughput single EV profiling methods are needed to better define EV subpopulations. Here, we present an antibody-based immunosequencing method that allows multiplexed measurement of protein molecules from individual nanometer-sized EVs. We use droplet microfluidics to compartmentalize and barcode individual EVs. The barcodes/antibody-DNA are then sequenced to determine protein composition. Using this highly sensitive technology, we detected specific proteins at the single EV level. We expect that this technology can be further adapted for multiplexed protein analysis of any nanoparticle.

Indexed as

Extracellular VesiclesNanostructuresAnimalsBiomarkersHumansBiomarkersdroplet microfluidicsextracellular vesicleshigh throughputmultiplexingsequencing

Identifiers

PMID33687214
PMCPMC8742254
OpenAlexW3135843649

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.